By Helgi Library - August 7, 2021
SimpleCell Europe made a net profit of CZK -31.9 mil with revenues of CZK 4.26 mil in 2020, up by 0.521% and down by 12...
By Helgi Library - August 7, 2021
SimpleCell Europe stock traded at CZK 252 per share at the end 2020 translating into a market capitalization of USD 11.8 mil. Sin...
By Helgi Library - August 7, 2021
SimpleCell Europe made a net profit of CZK -31.9 mil in 2020, up 0.521% compared to the previous year. Historically, between ...
| Profit Statement |
| Balance Sheet |
| Ratios |
| Valuation |
Get all company financials in excel:
Get all company financials in excel:
By Helgi Library - August 7, 2021
SimpleCell Europe stock traded at CZK 252 per share at the end 2020 implying a market capitalization of USD 11.8 mil. Since the end of 2015, stock has appreciated by % implying an annual average growth of % In absolute terms, the value of the company ros...
By Helgi Library - August 7, 2021
SimpleCell Europe made a net profit of CZK -31.9 mil with revenues of CZK 4.26 mil in 2020, up by 0.521% and down by 12.5%, respectively, compared to the previous year. This translates into a net margin of -748%. Historically, between 2018 and 2020, ...
By Helgi Library - August 7, 2021
SimpleCell Europe's net debt stood at CZK 47.0 mil and accounted for 62.6% of equity at the end of 2020. The ratio is down 10.1 pp compared to the previous year. Historically, the firm’s net debt to equity reached a high of 72.7% in 2019 and a lo...
By Helgi Library - August 7, 2021
SimpleCell Europe stock traded at CZK 252 per share at the end 2020 translating into a market capitalization of USD 11.8 mil. Since the end of 2015, the stock has appreciated by 0% representing an annual average growth of %. At the end of 2020, the firm ...
By Helgi Library - August 7, 2021
SimpleCell Europe's operating cash flow stood at in , up 0% when compared to the previous year. Historically, between 2021 - , the firm’s operating cash flow reached a high of CZK 126 mil in 2029 and a low of CZK -27.1 mil in 2022. SimpleCe...
By Helgi Library - August 6, 2021
SimpleCell Europe invested a total of in , down 0% compared to the previous year. Historically, between 2021 - , the company's investments stood at a high of CZK 17.9 mil in 2025 and a low of CZK 2.95 mil in 2028. As a percentage of ...
SimpleCell Europe has been growing its sales by 40.2% a year on average in the last 5 years. EBITDA has grown on average by 51.6% a year during that time to total of CZK 183 mil in 2029, or 14.4% of sales. That’s compared to 17.0% average margin seen in last five years.
The company netted CZK 148 mil in 2029 implying ROE of 33.5% and ROCE of 55.0%. Again, the average figures were 40.5% and 43.9%, respectively when looking at the previous 5 years.
SimpleCell Europe’s net debt amounted to CZK -125 mil at the end of 2029, or -31.3% of equity. When compared to EBITDA, net debt was -0.682x, down when compared to average of 0.085x seen in the last 5 years.
SimpleCell Europe stock traded at CZK 252 per share at the end of 2029 resulting in a market capitalization of USD 11.8 mil. Over the previous five years, stock price grew by 0% or 0% a year on average. The closing price put stock at a 12-month trailing EV/EBITDA of 0.713x and price to earnings (PE) of 2.06x as of 2029.
Helgi Library 
